This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies

NCT04689308 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
57
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Minghui Pharmaceutical (Shanghai) LTD